doi: 10.1007/BF01983330.
Mechanisms controlling the level of receptors for tumor necrosis factor
Affiliations
- PMID: 1647647
- DOI: 10.1007/BF01983330
Item in Clipboard
Mechanisms controlling the level of receptors for tumor necrosis factor
Agents Actions.
1991 Jan.
No abstract available
Similar articles
-
Regulation of the TNF-alpha receptor in human osteosarcoma cells: role of microtubules and of protein kinase C.Arch Biochem Biophys. 1993 Jan;300(1):287-92. doi: 10.1006/abbi.1993.1040. Arch Biochem Biophys. 1993. PMID: 7678725
-
Contrasting effects of the protein kinase C inhibitor, staurosporine, on cytokine and phorbol ester stimulation of fructose 2,6-bisphosphate and prostaglandin E production by fibroblasts in vitro. Comparative studies using interleukin-1 alpha, tumour necrosis factor alpha, transforming growth factor beta, interferon-gamma and 12-O-tetradecanoylphorbol 13-acetate.Biochem J. 1990 Aug 1;269(3):573-7. doi: 10.1042/bj2690573. Biochem J. 1990. PMID: 2117917 Free PMC article.
-
Downregulation of tumor necrosis factor receptors of macrophages by interferons and interleukin-1. Role of protein kinase C activation.J Biol Regul Homeost Agents. 1988 Oct-Dec;2(4):166-72. J Biol Regul Homeost Agents. 1988. PMID: 2471393
-
Tumor necrosis factor: receptor binding and mitogenic action in fibroblasts.J Cell Physiol Suppl. 1987;Suppl 5:57-61. doi: 10.1002/jcp.1041330412. J Cell Physiol Suppl. 1987. PMID: 2824534 Review.
-
Regulation of tumor necrosis factor receptors on phagocytes.Proc Soc Exp Biol Med. 1992 Sep;200(4):458-65. doi: 10.3181/00379727-200-43454a. Proc Soc Exp Biol Med. 1992. PMID: 1354872 Review. No abstract available.
Cited by
-
Interleukin-4 (IL-4) induces down-modulation and shedding of the p55 tumour necrosis factor receptor and inhibits TNF alpha's effect on rheumatoid synovial fibroblasts.Rheumatol Int. 1994;14(1):21-5. doi: 10.1007/BF00302667. Rheumatol Int. 1994. PMID: 7939136
-
From molecular to immuno-pharmacology: Schmiedeberg Medal for Klaus Resch.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul;398(7):7661-7665. doi: 10.1007/s00210-025-04129-4. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40232376 Free PMC article. No abstract available.